YU67002A - N-(heterociklil)benzen-ili-piridinsulfonamidi kao antitrombički i antikoagulirajući agensi - Google Patents

N-(heterociklil)benzen-ili-piridinsulfonamidi kao antitrombički i antikoagulirajući agensi

Info

Publication number
YU67002A
YU67002A YU67002A YUP67002A YU67002A YU 67002 A YU67002 A YU 67002A YU 67002 A YU67002 A YU 67002A YU P67002 A YUP67002 A YU P67002A YU 67002 A YU67002 A YU 67002A
Authority
YU
Yugoslavia
Prior art keywords
group
optionally substituted
represent
pyridine
sulphonamides
Prior art date
Application number
YU67002A
Other languages
English (en)
Inventor
Jean-Michael Alternburger
Gerard Cremer
Gilbert Lassalle
Mostafa Matrougul
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Priority to MEP-174/08A priority Critical patent/MEP17408A/xx
Publication of YU67002A publication Critical patent/YU67002A/sh
Publication of RS50370B publication Critical patent/RS50370B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Pronalazak se odnosi na jedinjenja formule (I) gde W moze predstavljati - (CH2)2- CH2-C≡C- ili -CH2-CH=CH-grupu; R2 moze posebno predstavljati piperidinil grupu, 1,2,3,6-tetrahidropiridinil grupu opciono supstituisanu, heksahidro-I(<I>H</I>)-azepinil grupu, piperazinil grupu opciono supstituisanu ili morfinopolinil grupu; R3 moze predstavljati -COR1- grupu; A moze posebno predstavljati fenil grupu opciono supstituisanu, heterociklicnu ili ciklopentil grupu i B moze posebno predstavljati piridil grupu, aminopirazinil grupu, aminopiridazinil grupu, pirimidinil grupu opciono supstituisanu amino grupom, piperidinil grupu ili aminopiridinil grupu opciono supstituisanu na piridinu sa (C1-C4)alkil ili (C1-C4)alkoksi grupom, amino grupu koja se moze opciono supstituisati sa (C1-C4)alkil grupom. Pronalazak se takodje odnosi na pripremanje pomenutih jedinjenja i njihovu terapeutsku upotrebu.
YUP-670/02A 2000-03-23 2001-03-22 N-(heterociklil)benzen-ili-piridinsulfonamidi kao antitrombički i antikoagulirajući agensi RS50370B (sr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MEP-174/08A MEP17408A (en) 2000-03-23 2001-03-22 N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0003724A FR2806722B1 (fr) 2000-03-23 2000-03-23 Derives de n-(heterocyclylbutyl) benzene-ou pyridine sulfonamide, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
YU67002A true YU67002A (sh) 2005-07-19
RS50370B RS50370B (sr) 2009-11-10

Family

ID=8848428

Country Status (35)

Country Link
US (1) US6680329B2 (sh)
EP (1) EP1268469B1 (sh)
JP (1) JP2003528098A (sh)
KR (1) KR100791693B1 (sh)
CN (1) CN1183128C (sh)
AR (1) AR029900A1 (sh)
AT (1) ATE269325T1 (sh)
AU (2) AU2001246617B2 (sh)
BG (1) BG65863B1 (sh)
BR (1) BR0109385A (sh)
CA (1) CA2401637C (sh)
DE (1) DE60103868T2 (sh)
DK (1) DK1268469T3 (sh)
EA (1) EA004986B1 (sh)
EE (1) EE05084B1 (sh)
ES (1) ES2222358T3 (sh)
FR (1) FR2806722B1 (sh)
HK (1) HK1051537A1 (sh)
HR (1) HRP20020762B1 (sh)
HU (1) HUP0300695A2 (sh)
IL (2) IL151619A0 (sh)
IS (1) IS2304B (sh)
ME (1) MEP17408A (sh)
MX (1) MXPA02009276A (sh)
NO (1) NO324835B1 (sh)
PL (1) PL204660B1 (sh)
PT (1) PT1268469E (sh)
RS (1) RS50370B (sh)
SI (1) SI1268469T1 (sh)
SK (1) SK286687B6 (sh)
TR (1) TR200402343T4 (sh)
TW (1) TWI290141B (sh)
UA (1) UA71667C2 (sh)
WO (1) WO2001070736A1 (sh)
ZA (1) ZA200206996B (sh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8729107B2 (en) * 2002-12-06 2014-05-20 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
CA2508165C (en) 2002-12-06 2014-05-06 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
US7750162B2 (en) 2004-04-19 2010-07-06 Daiso Co., Ltd. Process for preparation of nonnatural amino acid and intermediate thereof
EP1739077A4 (en) * 2004-04-19 2008-04-16 Daiso Co Ltd PROCESS FOR THE PRODUCTION OF NON-NATURAL AMINO ACIDS AND INTERMEDIATES THEREFOR
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
EP2276731A1 (en) * 2008-04-09 2011-01-26 Boehringer Ingelheim International GmbH 2-sulfonylamino-4-heteroaryl butyramide antagonists of ccr10
CA2725140A1 (en) * 2008-05-22 2009-11-26 Boehringer Ingelheim International Gmbh Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
AU2011210802B2 (en) * 2010-01-28 2014-10-16 The Medicines Company (Leipzig) Gmbh Trypsin-like serine protease inhibitors, and their preparation and use
FR2981071B1 (fr) * 2011-10-10 2014-02-07 Centre Nat Rech Scient Synthese versatile et stereospecifique d'acides amines gamma,delta-insatures par la reaction de wittig

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2727410B1 (fr) * 1994-11-25 1996-12-20 Synthelabo Chlorures de sulfonyles, leur preparation et leur utilisation comme intermediaires de synthese
FR2728570B1 (fr) * 1994-12-23 1997-04-11 Synthelabo Derives de 1-oxo-2-(phenylsulfonylamino)pentylpiperidine, leur preparation et leur application en therapeutique
FR2756285B1 (fr) * 1996-11-22 1998-12-18 Synthelabo Derives de n-(imidazolylbutyle)benzenesulfonamide, leur preparation et leur application en therapeutique
FR2756220B1 (fr) * 1996-11-27 1998-12-24 Lorraine Laminage Roue pour vehicule terrestre a moteur
FR2771094B1 (fr) * 1997-11-19 2000-02-04 Synthelabo Derives de piperidine-2-carboxylate, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
WO2001070736A1 (fr) 2001-09-27
NO324835B1 (no) 2007-12-17
IL151619A0 (en) 2003-04-10
AR029900A1 (es) 2003-07-23
TWI290141B (en) 2007-11-21
CN1426407A (zh) 2003-06-25
HRP20020762A2 (en) 2003-12-31
SK286687B6 (sk) 2009-03-05
HK1051537A1 (en) 2003-08-08
FR2806722B1 (fr) 2002-05-17
ZA200206996B (en) 2003-09-01
UA71667C2 (uk) 2004-12-15
NO20024496D0 (no) 2002-09-19
EA200200838A1 (ru) 2003-04-24
US20030207920A1 (en) 2003-11-06
EP1268469A1 (fr) 2003-01-02
PT1268469E (pt) 2004-10-29
BR0109385A (pt) 2003-06-03
MXPA02009276A (es) 2003-05-23
SI1268469T1 (en) 2004-10-31
PL204660B1 (pl) 2010-01-29
EA004986B1 (ru) 2004-10-28
MEP17408A (en) 2010-06-10
BG65863B1 (bg) 2010-03-31
RS50370B (sr) 2009-11-10
IL151619A (en) 2009-05-04
FR2806722A1 (fr) 2001-09-28
SK13512002A3 (sk) 2003-03-04
KR20020081476A (ko) 2002-10-26
TR200402343T4 (tr) 2004-12-21
DE60103868D1 (de) 2004-07-22
DE60103868T2 (de) 2005-06-09
EP1268469B1 (fr) 2004-06-16
US6680329B2 (en) 2004-01-20
PL364988A1 (en) 2004-12-27
IS6535A (is) 2002-08-30
NO20024496L (no) 2002-11-22
DK1268469T3 (da) 2004-10-11
ES2222358T3 (es) 2005-02-01
BG107130A (bg) 2003-06-30
CA2401637C (en) 2009-11-10
HUP0300695A2 (hu) 2003-07-28
AU2001246617B2 (en) 2006-03-02
JP2003528098A (ja) 2003-09-24
EE05084B1 (et) 2008-10-15
EE200200540A (et) 2004-04-15
IS2304B (is) 2007-10-15
CN1183128C (zh) 2005-01-05
ATE269325T1 (de) 2004-07-15
AU4661701A (en) 2001-10-03
HRP20020762B1 (en) 2005-02-28
CA2401637A1 (en) 2001-09-27
KR100791693B1 (ko) 2008-01-03

Similar Documents

Publication Publication Date Title
BG106390A (en) Novel spiro compounds
NO990667D0 (no) Depeptid-benzamidin som kinogenase-inhibitor
DE60112974D1 (en) Carbolinderivate
HRP20080664A2 (en) Substituted pyridine herbicides
PT1000035E (pt) 6-fenilfenantridinas substituidas
TR200201205T2 (tr) N-ikame edilmiş karbamoiloksialkil-azolyum türevleri.
DE59812455D1 (de) Fluorpyrazol-biphenylamide als fungizide
DE60216233D1 (en) Carbolinderivate
DK1042319T3 (da) Dihydrobenzofuraner
YU67002A (sh) N-(heterociklil)benzen-ili-piridinsulfonamidi kao antitrombički i antikoagulirajući agensi
NZ508758A (en) Substituted 2-(pyrazol-5-yl)-pyridine or pyrimidine derivatives useful as herbicidal agents
DK0810991T3 (da) 1-Aryl-2-acylamino-ethan-forbindelser og deres anvendelse som neurokinin- især neurokinin-1-antagonister
NO20001781L (no) 3-amino-3-arylpropan-1-og lignende-derivater, deres fremstilling og anvendelse
PE20050587A1 (es) Derivados de diazindol-dicarbonilo-piperazinilo como agentes antivirales
DE60112960D1 (de) Kondensierte pyridoindolderivate
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
MA27077A1 (fr) Derives de 2-amino-4-heteroarylethyl thiazoline et leur utilisation comme inhibiteurs de no-synthase inductible
NO20022123L (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
DE602004019094D1 (de) Pyrimidinen oder -chinazolinen als antimikrobielle mittel
NZ336091A (en) Aqueous disinfecting cleaning composition
DE60121048D1 (de) PYRAZINOi1&#39;2&#39;:1,6öPYRIDOi3,4-BöINDOLDERIVATE
DE60122559D1 (de) Indolderivate als pde5-inhibitoren
DK1104419T3 (da) N-substituerede azabicyloheptan-derivater, deres fremstilling og anvendelse
ATE154601T1 (de) 4-amino-2-(hetero)aryl-butanamide verwenbar als 5-ht1a-antagonisten
ATE360021T1 (de) Neue benzonaphthyridine